Abstract
BackgroundNo studies have been done to examine the efficacy of IVF and intrauterine insemination (IUI) for the treatment of young patients with unexplained infertility and low ovarian reserve, although it is becoming an increasingly significant indication for in-vitro fertilization (IVF). The goal of this research was to compare the efficacy of IVF with IUI on Poseidon group 3 patients with unexplained infertility (PG3&UI).MethodsThis was a retrospective analysis of PG3&UI patients who had IVF/intracytoplasmic sperm injection (ICSI) or IUI at the Third Affiliated Hospital of Guangzhou Medical University between January 1, 2015, and March 31, 2021. To equalize the baseline characteristics of the IVF/ICSI and IUI groups, propensity score matching (PSM) was utilized. Intention-to-treat (ITT) and per-protocol (PP) analyses were used to compare the differences in live births. To discover variations in time to biochemical pregnancy leading to live birth, Kaplan-Meier curves were produced. To evaluate the expenses per live birth between two procedures, a cost-effective analysis was done.ResultsAccording to ITT analysis, the live birth rate for the IVF/ICSI group was substantially higher than the cumulative live birth rate (CLBR) for the IUI group (22.6% (38/168) vs. 11.3% (19/168), RR 2.00, 95% CI 1.20-3.32, P = 0.006). In the PP analysis, the live birth rate was 23.0% (38/165) in the IVF/ICSI group and 11.7% (19/162) in the IUI group (RR = 1.96, 95% CI 1.18-3.26, P = 0.007). When censored at 365 days, the Kaplan-Meier analysis revealed that the IVF/ICSI group had a higher live birth rate than the IUI group (log-rank test χ²= 6.025; P = 0.014). However, when the two groups were censored at 180 days, the live birth rates were not substantially different (log-rank test χ²= 3.847; P = 0.05). The number of hospital visits per live birth in the IUI group was higher than in the IVF/ICSI group (85 vs. 48). The overall cost of a live birth was comparable across the two groups (¥132242 vs. ¥131611), while the medical expenses for a live delivery from IVF/ICSI were higher than those from IUI (¥118955 vs. ¥108279).ConclusionsThe livebirth rate per IVF/ICSI cycle with at most one embryo transfer is higher than the CLBR of IUI, with fewer hospital visits and similar expenses.
Highlights
Failure to conceive despite a year of regular unprotected intercourse in couples without anovulation, semen abnormalities, tubal disease, or other identifiable infertility reasons is classified as unexplained infertility
278 in-vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) and 189 intrauterine insemination (IUI) participants were enrolled in the research
The IVF/ICSI group had an anti-müllerian hormone (AMH) level of 0.82 ± 0.28 ng/mL, which was similar to the IUI group (0.83 ± 0.27 ng/mL) (|standard deviation (SD)|
Summary
Failure to conceive despite a year of regular unprotected intercourse in couples without anovulation, semen abnormalities, tubal disease, or other identifiable infertility reasons is classified as unexplained infertility. In a randomized controlled trial (RCT) involving 258 couples, Goverde et al compared the pregnancy rates of IVF and IUI. Custers et al compared the effectiveness of a single cycle of IVF with a single embryo transfer against three cycles of IUI/OS They demonstrated that the two groups had comparable rates of ongoing pregnancy and multiple pregnancies [3]. Conducted a RCT in women ≥38 years with unexplained infertility to evaluate therapy begun with IUI/OS vs immediate IVF. They discovered that after two cycles of treatment, IVF was associated with a greater CLBR [4]. The goal of this research was to compare the efficacy of IVF with IUI on Poseidon group 3 patients with unexplained infertility (PG3&UI)
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.